Recent Company News

• 08:54 AM ET Apr 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:08 AM ET May 07, 2025
  

  Quick Take - European biotech/pharma sector lower in sympathy move after FDA picks Vinay Prasad as CBER director

• 10:34 AM ET May 05, 2025
  

  StreetAccount M&A Summary: Week of 28-Apr

• 10:49 AM ET Apr 28, 2025
  

  StreetAccount M&A Summary: Week of 21-Apr

• 06:27 AM ET Apr 28, 2025
  

  StreetAccount Macro Headlines:

• 02:56 AM ET Apr 28, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:06 AM ET Apr 28, 2025
  

  Merck to acquire SpringWorks Therapeutics for $47/share in a equity value deal of ~$3.9B or enterprise value of $3.4B ($44.72, 0.00)

• 05:22 PM ET Apr 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:58 PM ET Apr 24, 2025
  

  Merck KGaA confirms late-stage discussions with SpringWorks Therapeutics on potential acquisition at basis price of ~$47 per share (€119.75, 0.00)